| Cost Comparison Charts |
Cost comparison charts |
April 2026 |
| Respiratory System |
Prescribing Data Report |
February 2026 |
| NHS Medicines Optimisation Opportunities Dashboard |
Prescribing Data Report |
May 2025 |
| Inhaler Carbon Footprint – MO opportunities |
Prescribing Data Report |
November 2025 |
| Budget impact of acetylcysteine vs carbocisteine |
Prescribing bulletin |
March 2024 |
| Inhaler Carbon Impact Assessment Tool |
Prescribing Data Report |
November 2025 |
| Sustainability: Environmental impact of inhaler disposal |
Prescribing bulletin |
August 2023 |
| Considerations for Sustainable Inhaler Prescribing |
Medicines in Practice |
March 2023 |
| Reducing the carbon impact of inhalers across the North of England |
Prescribing bulletin |
September 2021 |
| Omalizumab and dupilumab for chronic rhinosinusitis with nasal polyps |
Evaluation report |
September 2021 |
